Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Invariant Vα19i T cells regulate autoimmune inflammation

Nature Immunology volume 7, pages 987–994 (2006)Cite this article

Abstract

T cells expressing an invariant Vα19-Jα33 T cell receptor α-chain (Vα19i TCR) are restricted by the nonpolymorphic major histocompatibility complex class Ib molecule MR1. Whether Vα19i T cells are involved in autoimmunity is not understood. Here we demonstrate that T cells expressing the Vα19i TCR transgene inhibited the induction and progression of experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis. Similarly, EAE was exacerbated in MR1-deficient mice, which lack Vα19i T cells. EAE suppression was accompanied by reduced production of inflammatory mediators and increased secretion of interleukin 10. Interleukin 10 production occurred at least in part through interactions between B cells and Vα19i T cells mediated by the ICOS costimulatory molecule. These results suggest an immunoregulatory function for Vα19i T cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Characterization of NK1.1+ T cells from Vα19iTg mice.
Figure 2: Vα19i T cells in EAE.
Figure 3: Inhibition of EAE is associated with decreased TH1 cytokine production.
Figure 4: Interactions of Vα19i T cells and splenocytes induce IL-10.
Figure 5: Vα19i T cells induce B cells to secrete IL-10.
Figure 6: Vα19i T cell–induced IL-10 production is partially B cell dependent but completely MR1 independent.
Figure 7: ICOS–B7RP-1 costimulation contributes to Vα19i T cell–induced B cell IL-10 production.

Similar content being viewed by others

References

  1. Kronenberg, M. Toward an understanding of NKT cell biology: progress and paradox. Annu. Rev. Immunol. 23, 877–900 (2005).

    Article  CAS  Google Scholar 

  2. Treiner, E. et al. Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect. 7, 552–559 (2005).

    Article  CAS  Google Scholar 

  3. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 1626–1629 (1997).

    Article  CAS  Google Scholar 

  4. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786–1789 (2004).

    Article  CAS  Google Scholar 

  5. Okamoto, N. et al. Synthetic α-mannosyl ceramide as a potent stimulant for an NKT cell repertoire bearing the invariant Vα19-Jα26 TCR α chain. Chem. Biol. 12, 677–683 (2005).

    Article  CAS  Google Scholar 

  6. Chen, Y.H., Chiu, N.M., Mandal, M., Wang, N. & Wang, C.R. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 6, 459–467 (1997).

    Article  CAS  Google Scholar 

  7. Treiner, E. et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422, 164–169 (2003).

    Article  CAS  Google Scholar 

  8. Spada, F.M., Koezuka, Y. & Porcelli, S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188, 1529–1534 (1998).

    Article  CAS  Google Scholar 

  9. Tilloy, F. et al. An invariant T cell receptor α chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted α/β T cell subpopulation in mammals. J. Exp. Med. 189, 1907–1921 (1999).

    Article  CAS  Google Scholar 

  10. Godfrey, D.I., MacDonald, H.R., Kronenberg, M., Smyth, M.J. & Van Kaer, L. NKT cells: what's in a name? Nat. Rev. Immunol. 4, 231–237 (2004).

    Article  CAS  Google Scholar 

  11. Lehuen, A. et al. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831–1839 (1998).

    Article  CAS  Google Scholar 

  12. Mars, L.T. et al. Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J. Immunol. 168, 6007–6011 (2002).

    Article  CAS  Google Scholar 

  13. Wagner, M.J., Hussain, S., Mehan, M., Verdi, J.M. & Delovtch, T.L. A defect in lineage fate decision during fetal thymic invariant NKT cell development may regulate susceptibility to type 1 diabetes. J. Immunol. 174, 6764–6771 (2005).

    Article  CAS  Google Scholar 

  14. Pál, E. et al. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells. J. Immunol. 166, 662–668 (2001).

    Article  Google Scholar 

  15. Sharif, S. et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7, 1057–1062 (2001).

    Article  CAS  Google Scholar 

  16. Hong, S. et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7, 1052–1056 (2001).

    Article  CAS  Google Scholar 

  17. Miyamoto, K., Miyake, S. & Yamamura, T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413, 531–534 (2001).

    Article  CAS  Google Scholar 

  18. Chiba, A. et al. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of α-galactosylceramide. Arthritis Rheum. 50, 305–313 (2004).

    Article  CAS  Google Scholar 

  19. Miyake, S. & Yamamura, T. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5, 315–322 (2005).

    Article  CAS  Google Scholar 

  20. Chiba, A., Kaieda, S., Oki, S., Yamamura, T. & Miyake, S. The involvement of Vα14 natural killer T cells in the pathogenesis of arthritis in murine models. Arthritis Rheum. 52, 1941–1948 (2005).

    Article  CAS  Google Scholar 

  21. Kim, H.Y. et al. NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor β1 production. J. Exp. Med. 201, 41–47 (2005).

    Article  CAS  Google Scholar 

  22. Porcelli, S., Yockey, C.E., Brenner, M.B. & Balk, S.P. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4−8− α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain. J. Exp. Med. 178, 1–16 (1993).

    Article  CAS  Google Scholar 

  23. Shimamura, M. & Huang, Y.Y. Presence of a novel subset of NKT cells bearing an invariant Vα19.1-Jα26 TCR α chain. FEBS Lett. 516, 97–100 (2002).

    Article  CAS  Google Scholar 

  24. Kawachi, I., Maldonado, J., Strader, C. & Gilfillan, S. MR1-restricted Vα19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J. Immunol. 176, 1618–1627 (2006).

    Article  CAS  Google Scholar 

  25. Illés, Z., Shimamura, M., Newcombe, J., Oka, N. & Yamamura, T. Accumulation of Vα7.2-Jα33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int. Immunol. 16, 223–230 (2004).

    Article  Google Scholar 

  26. Illés, Z. et al. Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164, 4375–4381 (2000).

    Article  Google Scholar 

  27. Croxford, J.L., Feldmann, M., Chernajovsky, Y. & Baker, D. Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system. J. Immunol. 166, 4124–4130 (2001).

    Article  CAS  Google Scholar 

  28. Croxford, J.L. et al. Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system. J. Immunol. 160, 5181–5187 (1998).

    CAS  PubMed  Google Scholar 

  29. Cua, D.J., Groux, H., Hinton, D.R., Stohlman, S.A. & Coffman, R.L. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189, 1005–1010 (1999).

    Article  CAS  Google Scholar 

  30. Bettelli, E., Nicholson, L.B. & Kuchroo, V.K. IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis. J. Autoimmun. 20, 265–267 (2003).

    Article  CAS  Google Scholar 

  31. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233–240 (2005).

    Article  CAS  Google Scholar 

  32. Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D. & Anderton, S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944–950 (2002).

    Article  CAS  Google Scholar 

  33. Mauri, C., Gray, D., Mushtaq, N. & Londei, M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197, 489–501 (2003).

    Article  CAS  Google Scholar 

  34. Riegert, P., Wanner, V. & Bahram, S. Genomics, isoforms, expression, and phylogeny of the MHC class I-related MR1 gene. J. Immunol. 161, 4066–4077 (1998).

    CAS  PubMed  Google Scholar 

  35. Hayakawa, Y. et al. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166, 6012–6018 (2001).

    Article  CAS  Google Scholar 

  36. Ikarashi, Y. et al. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon γ production. J. Exp. Med. 194, 1179–1186 (2001).

    Article  CAS  Google Scholar 

  37. Kitamura, H. et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189, 1121–1128 (1999).

    Article  CAS  Google Scholar 

  38. Kaneda, H. et al. ICOS costimulates invariant NKT cell activation. Biochem. Biophys. Res. Commun. 327, 201–207 (2005).

    Article  CAS  Google Scholar 

  39. Hutloff, A. et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263–266 (1999).

    Article  CAS  Google Scholar 

  40. McAdam, A.J. et al. ICOS is critical for CD40-mediated antibody class switching. Nature 409, 102–105 (2001).

    Article  CAS  Google Scholar 

  41. Song, F. et al. Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: effects of flora and proinflammatory cytokines. J. Immunol. 162, 2275–2280 (1999).

    CAS  PubMed  Google Scholar 

  42. Kaneko, M., Akiyama, Y., Takimoto, H. & Kumazawa, Y. Mechanism of up-regulation of immunoglobulin A production in the intestine of mice unresponsive to lipopolysaccharide. Immunology 116, 64–70 (2005).

    Article  CAS  Google Scholar 

  43. Cognasse, F. et al. Differential downstream effects of CD40 ligation mediated by membrane or soluble CD40L and agonistic Ab: a study on purified human B cells. Int. J. Immunopathol. Pharmacol. 18, 65–74 (2005).

    Article  CAS  Google Scholar 

  44. Muhlen, K.A. et al. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J. Immunol. 172, 3034–3041 (2004).

    Article  Google Scholar 

Download references

Acknowledgements

We thank S. Gilfillan (Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri) for Mr1−/− mice. Supported by the Japan Society for the Promotion of Science (P03581 to J.L.C), the Ministry of Health, Labour and Welfare of Japan (T.Y. and S.M.), The Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (02-5 to T.Y.), Grant-in-Aid for Science Research on Priority Area from Ministry of Education, Science, Sports and Culture of Japan (17047051 to S.M.) and Grant-in-Aid for Scientific Research (B) (18390295 to S.M.) from the Japan Society for the Promotion of Science.

Author information

Authors and Affiliations

  1. Department of Immunology, National Institute of Neuroscience, National Centre of Neurology and Psychiatry, Tokyo, 187-8502, Japan

    J Ludovic Croxford, Sachiko Miyake & Takashi Yamamura

  2. Developmental Immunology Unit, Mitsubishi Kagaku Institute of Life Sciences, Tokyo, 194-8511, Japan

    Yi-Ying Huang & Michio Shimamura

Authors
  1. J Ludovic Croxford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sachiko Miyake
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi-Ying Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michio Shimamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takashi Yamamura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Yamamura.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

Expression of adhesion molecules on the surface of TCRβ+ T cells from Vα19iTgCd1d−/− mice is inhibited during EAE. (PDF 307 kb)

Supplementary Fig. 2

MOG35-55 peptide enhances Vα19i T cell-mediated IL-10 production. (PDF 255 kb)

Supplementary Table 1

Table shows primer gene names and sequences (5′ to 3′) used in this paper for real-time RT-PCR. (PDF 45 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Croxford, J., Miyake, S., Huang, YY. et al. Invariant Vα19i T cells regulate autoimmune inflammation. Nat Immunol 7, 987–994 (2006). https://doi.org/10.1038/ni1370

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni1370

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing